Nalaganje...

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating effective treatment to control the effects of hypercortisolism, and managing recurrence are challenging disease aspects to address. Mifepristone is a competitive glucocorticoid r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Med Insights Endocrinol Diabetes
Main Authors: Chang, Alice Y, Mirfakhraee, Sasan, King, Elizabeth E, Mercado, Jennifer U, Donegan, Diane M, Yuen, Kevin CJ
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940725/
https://ncbi.nlm.nih.gov/pubmed/33746521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551421994102
Oznake: Označite
Brez oznak, prvi označite!